Antiplatelet therapy for primary prevention of nonsignificant coronary lesions

doi:10.1016/j.rec.2025.01.019

Ampliar

Editorial comment
Antiplatelet therapy for primary prevention of nonsignificant coronary lesions

Tratamiento antiagregante en la prevención primaria de lesiones coronarias no significativas

Jose Antonio Esteban-ChapelaJuan Antonio Franco-PeláezaAlvaro Aceñaa b

Safety and efficacy of antiplatelet therapy in patients with intermediate coronary artery stenosis and deferred revascularization

David Hong, Seung Hun Lee, Jihye Heo, Doosup Shin, Juhee Cho, Eliseo Guallar, Hyun Sung Joh, Hyun Kuk Kim, Junho Ha, Ki Hong Choi, Taek Kyu Park, Jeong Hoon Yang, Young Bin Song, Joo-Yong Hahn, Seung-Hyuk Choi, Hyeon-Cheol Gwon, Danbee Kang, Joo Myung Lee

https://doi.org/10.1016/j.rec.2025.01.019

View PDF

Lea este artículo en español

Options

Identify yourself

Not yet a subscriber to the journal?

Revista Española de Cardiología (English Edition)

Subscribe to the journal

Purchase access to the article

By purchasing the article, the PDF of the same can be downloaded

Price: 19,34 €

Purchase now

Phone for incidents

Monday to Friday from 9am to 6pm (GMT+1) except for the months of July and August, which will be from 9am to 3pm

Calls from Spain 932 415 960

Calls from outside Spain +34 932 415 960

E-mail

atencionalcliente@elsevier.com